Search research articles
Contact Us
Filters
Showing results (41-50 of 160) with videos related to
Page
of 16
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 9, 2022
Botulinum toxin therapy: past, present and future developments
Dirk Dressler, Eric A Johnson
Journal of Clinical Movement Disorders
|
May 4, 2017
Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
Dirk Dressler, Fereshte Adib Saberi
Toxicology
|
October 3, 2022
The immunology of botulinum toxin therapy: A brief summary
Dirk Dressler, Hans Bigalke, Jürgen Frevert
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 4, 2005
Mouse diaphragm assay for detection of antibodies against botulinum toxin type B
Dirk Dressler, M Lange, Hans Bigalke
Neurology
|
March 13, 2002
Cabergoline can increase penile erections and libido
Matthias Wittstock, Reiner Benecke, Dirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 6, 2011
Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay
Dirk Dressler, Gerd Mander, Klaus Fink
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 5, 2026
Therapeutic botulinum toxin preparations: an update
Hans Bigalke, Jürgen Frevert, Dirk Dressler
Journal of Neurology
|
August 21, 2003
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure
Dirk Dressler, Hans Bigalke, Reiner Benecke
Journal of the Neurological Sciences
|
November 5, 2019
More than hemifacial spasm? A case of unilateral facial spasms with systematic review of red flags
Jirada Sringean, Dirk Dressler, Roongroj Bhidayasiri
Journal of Neural Transmission (Vienna, Austria : 1996)
|
June 28, 2018
Comparing incobotulinumtoxinA (Xeomin®) and onabotulinumtoxinA (Botox®): identical potency labelling in the hemidiaphragm assay
Dirk Dressler, Lizhen Pan, Hans Bigalke
Page
of 16
Search research articles
Search
Showing results (41-50 of 160) with videos related to
Sort By:
Page
of 16
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 9, 2022
Botulinum toxin therapy: past, present and future developments
Dirk Dressler, Eric A Johnson
Journal of Clinical Movement Disorders
|
May 4, 2017
Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
Dirk Dressler, Fereshte Adib Saberi
Toxicology
|
October 3, 2022
The immunology of botulinum toxin therapy: A brief summary
Dirk Dressler, Hans Bigalke, Jürgen Frevert
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 4, 2005
Mouse diaphragm assay for detection of antibodies against botulinum toxin type B
Dirk Dressler, M Lange, Hans Bigalke
Neurology
|
March 13, 2002
Cabergoline can increase penile erections and libido
Matthias Wittstock, Reiner Benecke, Dirk Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 6, 2011
Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay
Dirk Dressler, Gerd Mander, Klaus Fink
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 5, 2026
Therapeutic botulinum toxin preparations: an update
Hans Bigalke, Jürgen Frevert, Dirk Dressler
Journal of Neurology
|
August 21, 2003
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure
Dirk Dressler, Hans Bigalke, Reiner Benecke
Journal of the Neurological Sciences
|
November 5, 2019
More than hemifacial spasm? A case of unilateral facial spasms with systematic review of red flags
Jirada Sringean, Dirk Dressler, Roongroj Bhidayasiri
Journal of Neural Transmission (Vienna, Austria : 1996)
|
June 28, 2018
Comparing incobotulinumtoxinA (Xeomin®) and onabotulinumtoxinA (Botox®): identical potency labelling in the hemidiaphragm assay
Dirk Dressler, Lizhen Pan, Hans Bigalke
Page
of 16